Periodic Vortex Structures in Superfluid 3He-A

We discuss the general properties of periodic vortex arrangements in rotating superfluids. The different possible structures are classified according to the symmetry space-groups and the circulation number. We calculate numerically several types of vortex structures in superfluid 3He-A. The calculations are done in the Ginzburg-Landau region, but the method is applicable at all temperatures. A phase diagram of vortices is constructed in the plane formed by the magnetic field and the rotation velocity. The characteristics of the six equilibrium vortex solutions are discussed. One of these, the locked vortex 3, has not been considered in the literature before. The vortex sheet forms the equilibrium state of rotating 3He-A at rotation velocities exceeding 2.6 rad/s. The results are in qualitative agreement with experiments.Comment: 13 pages, 7 figures, http://boojum.hut.fi/research/theory/diagram.htm

Femtosecond optical parametric oscillator frequency combs

Techniques to measure and manipulate the carrier-envelope phase within femtosecond optical parametric oscillators (OPOs) allow their outputs to be stabilized in a way that produces a frequency comb structure, potentially tunable throughout the transparency band of the gain material. In this review we describe the fundamental principles of phase control, on which the development of singly- and doubly-resonant OPO frequency combs is based. We give examples of practical embodiments of such combs, and discuss in detail several applications, including spectroscopy, metrology, quantum computation and astrophotonics

[18F]2-Fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil

Decreased tumour [18F]2-fluoro-2-deoxy-D-glucose (18FDG) incorporation is related to response however its significance at the cell level in gastro-oesophageal cancer and how it relates to cell death is unknown. Here human gastric adenocarcinoma (AGS) cells were treated with lethal dose 10 and 50 (LD10 and LD50), determined by using the MTT assay, of the three drugs, epirubicin, 5-fluorouracil and cisplatin, commonly used in the treatment of patients with gastro-oesophageal cancer. 18FDG incorporation was determined after 48 and 72 h of treatment with each drug and related to drug-induced changes in glucose transport, hexokinase activity, cell cycle distribution and annexin V-PE binding (a measure of apoptosis). Treatment of cells for 48 and 72 h with LD50 doses of cisplatin resulted in reductions in 18FDG incorporation of 27 and 25% respectively and of 5-fluorouracil reduced 18FDG incorporation by 34 and 33% respectively: epirubicin treatment reduced incorporation by 30 and 69% respectively. Cells that had been treated for 72 h with each drug were incubated in drug-free media for a further 6 days to determine their ability to recover. Comparison of the ability to recover from the chemotherapy agent, with 18FDG incorporation before the recovery period allowed an assessment of the predictive ability of 18FDG incorporation. Cells treated with either 5-fluorouracil or cisplatin demonstrated recovery on removal of the drug. In contrast, cells treated with epirubicin did not recover corresponding with the greatest 72 h treatment decrease in 18FDG incorporation. In contrast to adherent cells treated with cisplatin or 5-fluorouracil, adherent epirubicin-treated cells also exhibited very high levels of apoptosis. Glucose transport was decreased after each treatment whilst hexokinase activity was only decreased after 72 h of treatment with each drug. There was no consistent relationship observed between 18FDG incorporation and cell cycle distribution. Our results show that at the tumour cell level in gastric tumour cells, decreased 18FDG incorporation and glucose transport, accompanies therapeutic growth inhibition. 18FDG incorporation is particularly diminished in cells exhibiting apoptosis